Viatris Cash on Hand 2010-2025 | VTRS

Viatris cash on hand for the quarter ending March 31, 2025 was $755M, a 25.59% decline year-over-year.

  • Viatris cash on hand for 2024 was $0.735B, a 25.92% decline from 2023.
  • Viatris cash on hand for 2023 was $0.992B, a 21.27% decline from 2022.
  • Viatris cash on hand for 2022 was $1.26B, a 79.68% increase from 2021.

Viatris Cash on Hand 2010-2025 | VTRS

  • Viatris cash on hand for 2024 was $0.735B, a 25.92% decline from 2023.
  • Viatris cash on hand for 2023 was $0.992B, a 21.27% decline from 2022.
  • Viatris cash on hand for 2022 was $1.26B, a 79.68% increase from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$139.4B
CVS Health (CVS)$80.1B
Elevance Health (ELV)$68.3B
Cencora (COR)$57.1B
DiDi Global (DIDIY)$27.2B
Labcorp Holdings (LH)$20.7B
Natera (NTRA)$19.6B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$13.9B
CochLear (CHEOY)$13.1B
Solventum (SOLV)$12.8B
ICON (ICLR)$11.9B
Revvity (RVTY)$11.3B
Medpace Holdings (MEDP)$9.2B
Avantor (AVTR)$9.1B
Sonic Healthcare (SKHHY)$8.8B
HealthEquity (HQY)$8.7B
Caris Life Sciences,�Inc (CAI)$8B
Charles River Laboratories (CRL)$7.7B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.2B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B
PACS (PACS)$1.9B